tiprankstipranks
Trending News
More News >

CTI BioPharma price target lowered to $8 from $10 at TD Cowen

TD Cowen analyst Boris Peaker lowered the firm’s price target on CTI BioPharma to $8 from $10 and keeps an Outperform rating on the shares. The analyst said we are updating our model and corresponding estimates as VONJO sales have been slower than initially anticipated.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on CTIC:

Disclaimer & DisclosureReport an Issue

1